North Star Investment Management Corp. Tekla Life Sciences Investors Transaction History

North Star Investment Management Corp.

$1.42 Billion
Q4 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Jul 20, 2018	SELL	$18.13 - $19.4 $25,653 - $27,450	-1,415 Closed	0 $0
Q1 2018 Apr 13, 2018	BUY	$18.92 - $21.52 $548 - $624	29 Added 2.09%	1,415 $27,000
Q4 2017 Jan 11, 2018	BUY	$18.31 - $22.24 $549 - $667	30 Added 2.21%	1,386 $27,000
Q3 2017 Oct 06, 2017	BUY	$20.12 - $21.88 $27,282 - $29,669	1,356	1,356 $29,000

Others Institutions Holding HQL

# of Institutions

79

Shares Held

9.65M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$44.7 Million
1.11% of portfolio
Penserra Capital Management LLC Orinda, CA

828K
Shares

$10.8 Million
0.2% of portfolio
Karpus Management, Inc. Pittsford, NY

490K
Shares

$6.38 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.43 Million
0.12% of portfolio
Absolute Investment Advisers LLC

400K
Shares

$5.21 Million
0.67% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.